Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA# and GA2LEN/HANNA* (Q34188879)

From Wikidata

Jump to navigation Jump to search

scientific article published on February 14, 2011

Language	Label	Description	Also known as
English	Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA# and GA2LEN/HANNA*	scientific article published on February 14, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA# and GA2LEN/HANNA* (English)

reason for preferred rank

most precise value

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA* (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

Andrzej Szczeklik

17

object named as

A Szczeklik

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Marek L. Kowalski

1

object named as

Marek L Kowalski

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Ewa Niżankowska-Mogilnicka

11

object named as

E Niżankowska-Mogilnicka

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Grażyna Bochenek

5

object named as

G Bochenek

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Mario Sanchez-Borges

13

object named as

M Sanchez-Borges

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4

object named as

S. Bavbek

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

9

object named as

P. Demoly

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

10

object named as

E. R. Gomes

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

Antonino Romano

12

object named as

A. Romano

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

15

object named as

M. J. Torres

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

author name string

J. S. Makowska

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

M. Blanca

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

J. Bousquet

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

P. Bousquet

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

G. Celik

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

M. Sanz

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

A. De Weck

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

K. Brockow

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21631520

3 December 2024

publication date

14 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

full work available at URL

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1398-9995.2011.02557.x

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:21631520

3 December 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111/j.1398-9995.2011.02557.x

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1398-9995.2011.02557.x/fullpdf

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

66

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

818-829

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Epidemiology of hypersensitivity drug reactions

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Aspirin intolerance and recurrent urticaria in normal adults and children. Epidemiology and review

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Self-reported drug allergy in a general adult Portuguese population

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Multiple NSAID intolerance in chronic idiopathic urticaria is correlated with delayed, pronounced and prolonged autoreactivity

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Anaphylaxis: risk factors for recurrence

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Clinical features of acute anaphylaxis in patients admitted to a university hospital: an 11-year retrospective review (1985-1996).

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Oral aspirin challenges in patients with a history of intolerance to single non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Serious skin reactions and selective COX-2 inhibitors: a case series from prescription-event monitoring in England

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Intolerance to aspirin. Clinical studies and consideration of its pathogenesis

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

The natural history and clinical characteristics of aspirin-exacerbated respiratory disease

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

The broken balance in aspirin hypersensitivity

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Contribution of aspirin-intolerant asthma to near fatal asthma based on a questionnaire survey in Niigata Prefecture, Japan

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patients

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

A new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Basophil activation tests in the evaluation of immediate drug hypersensitivity

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Involvement of 15-lipoxygenase and prostaglandin EP receptors in aspirin-triggered 15-hydroxyeicosatetraenoic acid generation in aspirin-sensitive asthmatics

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin-Sensitive Patients Identification Test (ASPITest)

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Tolerability of selective cyclooxygenase inhibitor, celecoxib, in patients with analgesic intolerance

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects.

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Aspirin sensitivity and desensitization for asthma and sinusitis

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Asthma outcomes after endoscopic sinus surgery in aspirin-tolerant versus aspirin-induced asthmatic patients

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Hypersensitivity to aspirin: common eicosanoid alterations in urticaria and asthma

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Clinical course and urinary eicosanoids in patients with aspirin-induced urticaria followed up for 4 years

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Association between asthma, rhinitis and NSAID hypersensitivity in chronic urticaria patients and prevalence rates

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Predictive value of autologous plasma skin test for multiple nonsteroidal anti-inflammatory drug intolerance.

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Safety of cyclooxygenase 2 inhibitors and increased leukotriene synthesis in chronic idiopathic urticaria with sensitivity to nonsteroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Risk factors for acetaminophen and nimesulide intolerance in patients with NSAID-induced skin disorders

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Tolerability to new COX-2 inhibitors in NSAID-sensitive patients with cutaneous reactions

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Prevention and treatment of reactions to NSAIDs

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Leukotriene receptor antagonists may prevent NSAID-induced exacerbations in patients with chronic urticaria

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Selective immediate hypersensitivity reactions to NSAIDs

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone.

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974-1994) and review of the literature

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Atopy is a risk factor for non-steroidal anti-inflammatory drug sensitivity

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients.

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Delayed drug hypersensitivity reactions - new concepts

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Risk of skin reactions when using ibuprofen-based medicines

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Fixed drug eruption due to naproxen; lack of cross-reactivity with other propionic acid derivatives

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Recurrent aseptic meningitis due to different non-steroidal anti-inflammatory drugs including rofecoxib

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Glomerular, tubular and interstitial nephritis associated with non-steroidal antiinflammatory drugs. Evidence of a common mechanism

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Photosensitivity to ketoprofen: mechanisms and pharmacoepidemiological data.

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Reproducible identification of the causative drug of a fixed drug eruption by oral provocation and lesional patch testing

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

The lymphocyte transformation test in the diagnosis of drug hypersensitivity

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Hypersensitivity to non-steroidal anti-inflammatory drugs in childhood

1 reference

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

21 January 2018

Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes

3

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Challenge-based clinical patterns of 223 Spanish patients with nonsteroidal anti-inflammatory-drug-induced-reactions

13

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective

16

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients

19

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Aspirin-sensitive rhinosinusitis and asthma

22

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Aspirin-sensitive rhinosinusitis/asthma: spectrum of adverse reactions to aspirin

23

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma

30

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Use of nonsteroidal anti-inflammatory drugs in patients with aspirin hypersensitivity : safety of cyclo-oxygenase-2 inhibitors

42

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Nonsteroidal anti-inflammatory drug hypersensitivity: fable or reality?

54

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Rapid oral challenge-desensitization for patients with aspirin-related urticaria-angioedema

59

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients

62

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Association of chronic urticaria with thyroid autoimmunity and Raynaud phenomenon with anticentromere antibodies

63

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Idiosyncrasy to Pyrazolone Drugs

64

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens

66

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Diagnosis of pyrazolone drug sensitivity: clinical history versus skin testing and in vitro testing

67

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Paracetamol (acetaminophen) hypersensitivity

69

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Selective hypersensitivity to diclofenac

72

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Current causes of fixed drug eruption in the UK

79

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Fixed drug eruption from piroxicam

80

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Pulmonary alveolitis and NSAIDs--fact or fiction?

86

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

COX-2 inhibitors and acute interstitial nephritis: case report and review of the literature.

89

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Topical NSAID allergic contact dermatitis. Italian experience

90

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Photopatch test reactivity: effect of photoallergen concentration and UVA dosaging

93

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations

95

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Evaluation of drug-related hypersensitivity reactions in children

98

1 reference

10.1111/J.1398-9995.2011.02557.X

https://api.crossref.org/works/10.1111/J.1398-9995.2011.02557.X

3 December 2024

Identifiers

10.1111/J.1398-9995.2011.02557.X

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34188879&oldid=2283096706"